全文获取类型
收费全文 | 8485篇 |
免费 | 474篇 |
国内免费 | 133篇 |
专业分类
耳鼻咽喉 | 127篇 |
儿科学 | 153篇 |
妇产科学 | 81篇 |
基础医学 | 1410篇 |
口腔科学 | 142篇 |
临床医学 | 707篇 |
内科学 | 1781篇 |
皮肤病学 | 481篇 |
神经病学 | 626篇 |
特种医学 | 518篇 |
外科学 | 1027篇 |
综合类 | 23篇 |
现状与发展 | 1篇 |
一般理论 | 1篇 |
预防医学 | 311篇 |
眼科学 | 192篇 |
药学 | 844篇 |
中国医学 | 143篇 |
肿瘤学 | 524篇 |
出版年
2024年 | 7篇 |
2023年 | 74篇 |
2022年 | 241篇 |
2021年 | 340篇 |
2020年 | 179篇 |
2019年 | 231篇 |
2018年 | 284篇 |
2017年 | 232篇 |
2016年 | 322篇 |
2015年 | 400篇 |
2014年 | 511篇 |
2013年 | 483篇 |
2012年 | 786篇 |
2011年 | 774篇 |
2010年 | 404篇 |
2009年 | 372篇 |
2008年 | 499篇 |
2007年 | 443篇 |
2006年 | 346篇 |
2005年 | 380篇 |
2004年 | 266篇 |
2003年 | 225篇 |
2002年 | 226篇 |
2001年 | 177篇 |
2000年 | 186篇 |
1999年 | 130篇 |
1998年 | 52篇 |
1997年 | 29篇 |
1996年 | 38篇 |
1995年 | 17篇 |
1994年 | 32篇 |
1993年 | 16篇 |
1992年 | 41篇 |
1991年 | 44篇 |
1990年 | 37篇 |
1989年 | 51篇 |
1988年 | 31篇 |
1987年 | 30篇 |
1986年 | 26篇 |
1985年 | 22篇 |
1984年 | 10篇 |
1983年 | 6篇 |
1981年 | 9篇 |
1980年 | 14篇 |
1979年 | 15篇 |
1978年 | 7篇 |
1977年 | 9篇 |
1971年 | 4篇 |
1970年 | 4篇 |
1967年 | 4篇 |
排序方式: 共有9092条查询结果,搜索用时 15 毫秒
61.
62.
Pulmonary atresia with intact ventricular septum (PAIVS) is a rare congenital cardiac anomaly that has been classified into
two types: one is a more frequent type having dysplasia of tricuspid valve (TV) with a small annulus, underdeveloped right
ventricle (RV) with a hypoplastic cavity and a hypertrophic wall; the other type has severe dysplasia of TV and dilatation
of RV, right atrium (RA), and right atrioventricular junction with thinning of the RV wall.
We performed a morphologic study on 11 autopsied hearts with PAIVS, giving particular emphasis to the variation of morphology
of the TV. We could classify these hearts into 3 groups according to the degree of right ventricular development. In the first
group of 7 cases (type I), the RVs were underdeveloped. Thick leaflets, restricted valve apparatus with short chordae, and
small annuli were characteristics of the TV. In the second group of 3 cases (type II), the RVs showed marked enlargement of
the cavity and thinning of the wall. The TV showed redundant, dysplastic, sail-like anterior leaflets, and the downward displacement
of septal leaflet and/or posterior leaflet, which are the findings frequently observed in Ebstein's malformation. The RVs
were dilated and with partially unguarded tricuspid orifice. The septal leaflet of the TV was dysplastic and, in two cases,
the septal leaflet showed chordal structure at the upper surface facing the RA, which is a peculiar finding that has not been
described in the literature. The remaining case was a heart with a moderately developed RV (type III). The TV showed mildly
dysplastic appearance and we classify this as a separate type, because we could expect the best surgical results in this type.
This type had optimal size of RV and the mildest degree of dysplasia of TV. In PAIVS, the morphology of TV correlates well
with the type of the right ventricular development. 相似文献
63.
64.
65.
66.
Yoo Na Jang Yong Jik Lee Yoon Mi Han Hyun Min Kim Hong Seog Seo Ji Hoon Jeong Seung Yeon Park Tae Woo Jung 《Yonsei medical journal》2022,63(6):530
PurposeSince diabetes and hypertension frequently occur together, it is thought that these conditions may have a common pathogenesis. This study was designed to evaluate the anti-diabetic function of the anti-hypertensive drug fimasartan on C2C12 mouse skeletal muscle and HepG2 human liver cells in a high glucose state.Materials and MethodsThe anti-diabetic effects and mechanism of fimasartan were identified using Western blot, glucose uptake tests, oxygen consumption rate (OCR) analysis, adenosine 5′-triphosphate (ATP) enzyme-linked immunosorbent assay (ELISA), and immunofluorescence staining for diabetic biomarkers in C2C12 cells. Protein biomarkers for glycogenolysis and glycogenesis were evaluated by Western blotting and ELISA in HepG2 cells.ResultsThe protein levels of phosphorylated 5′ adenosine monophosphate-activated protein kinase (p-AMPK), p-AKT, insulin receptor substrate-1 (IRS-1), and glucose transporter type 4 (Glut4) were elevated in C2C12 cells treated with fimasartan. These increases were reversed by peroxisome proliferator-activated receptor delta (PPARδ) antagonist. ATP, OCR, and glucose uptake were increased in cells treated with 200 µM fimasartan. Protein levels of glycogen phosphorylase, glucose synthase, phosphorylated glycogen synthase, and glycogen synthase kinase-3 (GSK-3) were decreased in HepG2 cells treated with fimasartan. However, these effects were reversed following the addition of the PPARδ antagonist GSK0660.ConclusionIn conclusion, fimasartan ameliorates deteriorations in glucose metabolism as a result of a high glucose state by regulating PPARδ in skeletal muscle and liver cells. 相似文献
67.
While ultrasound (US) is considered an important tool for hepatocellular carcinoma (HCC) surveillance, it has limited sensitivity for detecting early-stage HCC. Abbreviated MRI (AMRI) has recently gained popularity owing to better sensitivity in its detection of early-stage HCC than US, while also minimizing the time and cost in comparison to complete contrast-enhanced MRI, as AMRI includes only a few essential sequences tailored for detecting HCC. Currently, three AMRI protocols exist, namely gadoxetic acid-enhanced hepatobiliary-phase AMRI, dynamic contrast-enhanced AMRI, and non-enhanced AMRI. In this study, we discussed the rationale and technical details of AMRI techniques for achieving optimal surveillance performance. The strengths, weaknesses, and current issues of each AMRI protocol were also elucidated. Moreover, we scrutinized previously performed AMRI studies regarding clinical and technical factors. Reporting and recall strategies were discussed while considering the differences in AMRI protocols. A risk-stratified approach for the target population should be taken to maximize the benefits of AMRI and the cost-effectiveness should be considered. In the era of multiple HCC surveillance tools, patients need to be fully informed about their choices for better adherence to a surveillance program. 相似文献
68.
Naoyuki Kanayama Fumiaki Isohashi Yasuo Yoshioka Sungjae Baek Masashi Chatani Tadayuki Kotsuma Eiichi Tanaka Ken Yoshida Yuji Seo Osamu Suzuki Seiji Mabuchi Yasuhiko Shiki Keiji Tatsumi Tadashi Kimura Teruki Teshima Kazuhiko Ogawa 《Journal of radiation research》2015,56(2):346-353
The purpose of this study was to determine the outcomes and optimal practice patterns of definitive radiotherapy for primary vaginal cancer. Between 1993 and 2012, 49 patients were treated with definitive radiotherapy for primary vaginal cancer in three hospitals. Of these, 15 patients (31%) had clinically positive regional lymph node metastasis. A total of 34 patients (70%) received external beam radiotherapy with high-dose-rate brachytherapy (interstitial or intracavitary), and 8 (16%) (with small superficial Stage I tumors) were treated with local radiotherapy. The median follow-up was 33 months (range: 1–169 months). The 3-year overall survival (OS), disease-free survival (DFS), and loco-regional control (LRC) rates were 83%, 59% and 71%, respectively. In multivariate analysis, the histological type (P = 0.044) was significant risk factors for LRC. In Federation of Gynecology and Obstetrics (FIGO) Stage I cases, 3 of 8 patients (38%) who did not undergo prophylactic lymph node irradiation had lymph node recurrence, compared with 2 of 12 patients (17%) who underwent prophylactic pelvic irradiation. For Stage III–IV tumors, the local recurrence rate was 50% and the lymph node recurrence rate was 40%. Patients with FIGO Stage I/II or clinical Stage N1 had a higher recurrence rate with treatment using a single modality compared with the recurrence rate using combined modalities. In conclusion, our treatment outcomes for vaginal cancer were acceptable, but external beam radiotherapy with brachytherapy (interstitial or intracavitary) was needed regardless of FIGO stage. Improvement of treatment outcomes in cases of FIGO Stage III or IV remains a significant challenge. 相似文献
69.
Dai Hyun Kim Jun Hyuk Cho Sung Jin Park Soo Hong Seo Hyo Hyun Ahn 《Journal of Korean medical science》2022,37(24)
BackgroundPityriasis rosea (PR) is a papulosquamous eruption with generally unknown origin but suspected to be related to viral etiologies. The clinicopathological spectrum of several disorders with viral etiologies has been altered after the coronavirus disease 2019 (COVID-19) pandemic. The author group could experience coherent histological alterations in PR after the COVID-19 pandemic. This study aimed to investigate how the clinicopathological findings of PR were changed after the COVID-19 pandemic.MethodsPatients (n = 11) diagnosed with PR based on the clinical manifestations and skin biopsies between February 2018 and October 2019 and 11 patients in February 2020 and October 2021 were retrospectively analyzed by investigating the medical records.ResultsThe patients with PR during the COVID-19 pandemic demonstrated statistically significant histopathological alterations from classic brisk and dense infiltration pattern to dormant and sparse infiltration and psoriasiform-dominant patterns (P = 0.019). PR was associated with more frequent pruritus during the pandemic period (P = 0.027).ConclusionIn conclusion, PR demonstrated a significant histopathological alteration with more frequent pruritus during the COVID-19 pandemic. The comparative results about clinicopathological findings of PR will provide a useful reference for dermatologists in the diagnostic process of PR in the COVID-19 pandemic. 相似文献
70.
Hyonsoo Joo So-Young Park So Young Park Seo Young Park Sang-Heon Kim You Sook Cho Kwang Ha Yoo Ki Suck Jung Chin Kook Rhee 《Journal of Korean medical science》2022,37(30)
BackgroundAsthma and chronic obstructive pulmonary disease (COPD) are airway diseases with similar clinical manifestations, despite differences in pathophysiology. Asthma-COPD overlap (ACO) is a condition characterized by overlapping clinical features of both diseases. There have been few reports regarding the prevalence of ACO in COPD and severe asthma cohorts. ACO is heterogeneous; patients can be classified on the basis of phenotype differences. This study was performed to analyze the prevalence of ACO in COPD and severe asthma cohorts. In addition, this study compared baseline characteristics among ACO patients according to phenotype.MethodsPatients with COPD were prospectively enrolled into the Korean COPD subgroup study (KOCOSS) cohort. Patients with severe asthma were prospectively enrolled into the Korean Severe Asthma Registry (KoSAR). ACO was defined in accordance with the updated Spanish criteria. In the COPD cohort, ACO was defined as bronchodilator response (BDR) ≥ 15% and ≥ 400 mL from baseline or blood eosinophil count (BEC) ≥ 300 cells/μL. In the severe asthma cohort, ACO was defined as age ≥ 35 years, smoking ≥ 10 pack-years, and post-bronchodilator forced expiratory volume in 1 s/forced vital capacity < 0.7. Patients with ACO were divided into four groups according to smoking history (threshold: 20 pack-years) and BEC (threshold: 300 cells/μL).ResultsThe prevalence of ACO significantly differed between the COPD and severe asthma cohorts (19.8% [365/1,839] vs. 12.5% [104/832], respectively; P < 0.001). The percentage of patients in each group was as follows: group A (light smoker with high BEC) – 9.1%; group B (light smoker with low BEC) – 3.7%; group C (moderate to heavy smoker with high BEC) – 73.8%; and group D (moderate to heavy smoker with low BEC) – 13.4%. Moderate to heavy smoker with high BEC group was oldest, and showed weak BDR response. Age, sex, BDR, comorbidities, and medications significantly differed among the four groups.ConclusionThe prevalence of ACO differed between COPD and severe asthma cohorts. ACO patients can be classified into four phenotype groups, such that each phenotype exhibits distinct characteristics. 相似文献